Gas Supply For Domestic Use Remains Sufficient, Says Minister

KUALA LUMPUR, June 3 -- Malaysia’s gas supply remains sufficient for now, with the majority of the country’s electricity generation supported by domestic sources, according to Science, Technology and Innovation Minister Datuk Chang Lih Kang. He said authorities continue to monitor developments in the industry. “About 80 per cent of electricity generation in Malaysia is supported by domestic sources, so we are not too dependent on external supplies. “For now, supply is adequate, and there is no cause for major concern,” he told reporters after launching the ‘Revolutionising Industry with Graphene’ initiative here today. Meanwhile, Gas Malaysia Bhd president and chief executive officer Azli Mohamed said the industry is not facing any supply constraints, with the company’s primary source of gas coming from Petroliam Nasional Bhd (Petronas). “Our reliance on the Middle East is minimal. Our supply comes mainly from domestic sources and Australia. Essentially, there are no issues meeting industry demand, and we are able to supply our more than 1,000 customers,” he said. However, Azli noted that the industry could still face indirect challenges, including higher transportation costs and supply chain disruptions. He cited the rubber industry as an example, as it depends on raw materials sourced from countries such as South Korea and China. -- BERNAMA

KUALA LUMPUR, June 3 — Malaysia’s gas supply remains sufficient for now, with the majority of the country’s electricity generation supported by domestic sources, according to Science, Technology and Innovation Minister Datuk Chang Lih Kang. He said authorities continue to monitor developments in the industry. “About 80 per cent of electricity generation in Malaysia is […]

PROMISE Technology Brings Sustainability Focus to AI Storage at COMPUTEX 2026

TAIPEI, May 25, 2026 /PRNewswire/ -- PROMISE Technology, a global innovator in enterprise storage solutions, announced it will showcase its latest AI-optimized storage portfolio at COMPUTEX 2026, highlighting a strategic focus on performance, storage expansion, and energy efficiency. Taking place June 2–5 at the Taipei Nangang Exhibition Center, COMPUTEX 2026 is one of the world's premier technology exhibitions. PROMISE will host live demonstrations at Booth R0708 in Hall 2 (TaiNEX 2). PROMISE's latest solutions are engineered for enterprise, AI datacenters, surveillance, and media & entertainment environments. The company will demonstrate how intelligent storage architectures can address key AI infrastructure challenges—particularly power constraints and capacity expansion—while sustaining the high performance required for next-generation workloads. optimized storage with features like NVMeBoost and GreenBoost 2.0. Featured Products at COMPUTEX 2026 BoosTrak Series A purpose-built dual-node (Compute & Storage nodes), all-NVMe storage platform with RDMA/RoCE and 100/200/400GbE connectivity. Designed for ultra-low latency and high-throughput AI and datacenter workloads, it debuts the latest evolution of NVMeBoost™. VTrak 8206 NVMe All-Flash Built on PCIe Gen5 with NVMe-oF support, this enterprise platform is optimized for AI-driven applications and real-time analytics. Vess A8340 A fully integrated AI and intelligent surveillance platform powered by multi-GPU architecture and Intel® Xeon® 6 processors. With six PCIe Gen5 x16 slots, it combines storage, compute, and video analytics in a single scalable system. Pegasus5 R12 Pro A hybrid Thunderbolt™ 5 storage solution with 12 HDD bays and 2 NVMe SSD bays, delivering up to 6,000 MB/s for demanding 4K/8K production workflows. Pegasus5 N4 A portable Thunderbolt™ 5 NVMe device offering up to 80Gbps bandwidth and 6,000 MB/s speeds, ideal for mobile and on-location creative work. GreenBoost™ 2.0: Keep GPUs Busy. Not Power-Hungry By reducing storage power consumption, GreenBoost 2.0 enables higher GPU utilization and supports larger-scale AI deployments within existing power and cooling limits. Developed in collaboration with Toshiba, GreenBoost 2.0 integrates high-density JBOD architectures with energy-efficient, high-capacity HDDs to deliver a balanced approach to performance and sustainability. James Lee, CEO of PROMISE Technology, commented: "We are happy to continue working with Toshiba, beginning with GreenBoost 1.0 onward to GreenBoost 2.0, advancing AI-driven storage and sustainable infrastructure at COMPUTEX. As enterprises scale AI, power and cooling have become defining constraints. Through deep hardware and software integration, we are enabling customers to achieve both performance and energy efficiency at scale." Noriaki Katakura, Division President, Storage Products Division, Toshiba Electronics Components Taiwan Corporation added: "As AI drives rapid data growth, enterprises need higher density with lower energy consumption. Through our collaboration with PROMISE Technology, combining high-density JBOD architecture and GreenBoost 2.0 with Toshiba's high capacity NL HDDs, we deliver an efficient, scalable foundation for modern data centers. We look forward to advancing ecosystem collaboration to support AI workloads while meeting sustainability goals." NVMeBoost™ PROMISE proprietary feature NVMeBoost creates an optimized data pipeline—accelerating storage-to-GPU transfers while improving inter-GPU communication. NVMeBoost represents a major step forward in making GPU-accelerated storage and high-speed networking accessible to mainstream enterprises. Organizations can achieve breakthrough performance for AI and data-intensive workloads while leveraging existing infrastructure. For more information or to schedule a meeting at COMPUTEX 2026, visit www.promise.com Booth: R0708 About PROMISE Technology PROMISE Technology is a leading provider of high-performance storage solutions for enterprise, AI, surveillance, media & entertainment, and creative professionals. With a focus on innovation, reliability, and sustainability, PROMISE delivers intelligent storage architectures for the world's most demanding data environments. Source: PROMISE Technology

TAIPEI, May 25, 2026 /PRNewswire/ — PROMISE Technology, a global innovator in enterprise storage solutions, announced it will showcase its latest AI-optimized storage portfolio at COMPUTEX 2026, highlighting a strategic focus on performance, storage expansion, and energy efficiency. Taking place June 2–5 at the Taipei Nangang Exhibition Center, COMPUTEX 2026 is one of the world’s […]

Informa Markets Puts Bangkok at the Center of Southeast Asia’s Pharma Industry, Uniting 400 Exhibitors, Experts from 70 Countries at CPHI South East Asia

BANGKOK, May 24, 2026 /PRNewswire/ -- Informa Markets sets to organise CPHI South East Asia from 8–10 July 2026 at Queen Sirikit National Convention Center under the theme "The Gateway to the ASEAN Pharma Industry." The event is a comprehensive pharmaceutical manufacturing exhibition, technology showcase, and conference for Southeast Asia, featuring innovations from more than 400 companies worldwide. Highlights include international pavilion zones from eight markets, showcasing innovation trends from Mainland China, India, Indonesia, Malaysia, South Korea, Taiwan, Thailand, Vietnam, and Egypt. The event will also provide business matching opportunities and over 60 academic conference sessions. Organisers expect more than 10,000 visitors from over 70 countries during the three-day event, creating new business opportunities throughout the exhibition. Ms. Rungphech Chitanuwat, Regional Portfolio Director – ASEAN at Informa Markets said, "The pharmaceutical industry in Thailand continues to show strong growth potential, supported by several factors including the country's transition into a fully aged society, the increasing prevalence of non-communicable diseases (NCDs), healthcare system expansion, growth in medical tourism, and the use of essential medicines in hospitals under Thailand's universal healthcare system. In 2024, Thailand's pharmaceutical industry was valued at approximately THB 240 billion (around 6.9 billion dollars), and is projected to grow by 6–7% due to these supporting factors. Market research agencies also forecast that by 2030, the industry could reach a value of 480 billion baht or 13.9 billion dollars. Another key trend to watch is the increasing push from both the public and private sectors toward pharmaceutical development and innovation, including both generic drugs and newly developed medicines. This aligns with government efforts to strengthen pharmaceutical security. Pharmaceutical and healthcare security has therefore become a national policy priority aimed at raising public healthcare standards and strengthening the country's economy as Thailand seeks to join the OECD within five years. Policies also focus on reducing reliance on imported medicines, supporting domestic active pharmaceutical ingredient (API) production, and increasing manufacturing capacity for essential medicines in line with actual production costs. This is the driving force behind the organization of CPHI South East Asia, a technology and innovation exhibition with the important goal of contributing to Thailand's pharmaceutical security. The event aims to help drive both healthcare and the economy forward, positioning Thailand as a Medical Hub for Southeast Asia through internationally standardized pharmaceutical manufacturing and enhanced competitiveness in global export markets. Ms. Rungphech added, "Pharmaceutical security is a shared responsibility and a foundation of human security. Government and private sector must work in tandem to ensure Thailand not only has access to medicines, but becomes a country that the world trusts to produce them." "CPHI South East Asia is part of International Healthcare Week and will be held at Queen Sirikit National Convention Center from 8–10 July 2026 under the theme "The Gateway to the ASEAN Pharma Industry." The event will contribute to advancing Thailand's pharmaceutical industry in line with the country's strategic development goals." Ms. Supatra Boonserm, Secretary-General of the Food and Drug Administration (FDA), under the Food and Drug Administration Office (Thai FDA), Ministry of Public Health, stated that in a world where medical technology continues to advance rapidly, we are now entering the era of Advanced Therapy Medicinal Products (ATMPs). These are no longer just "medicines" in the traditional sense, but represent "new hope" for treating diseases once considered incurable — whether through cell therapy, gene therapy, or tissue engineering. Today, the role of the Thai FDA is no longer limited to being merely a "regulator" responsible for screening product safety. It has evolved into an "Innovation Facilitator," aiming to position Thailand as a true regional healthcare hub. The FDA's key mission in supporting ATMPs is built upon three major pillars: 1.Creating a Regulatory "Fast Track" (Regulatory Excellence) Complex innovations require regulations that are both flexible and rigorous. The FDA has therefore developed legal frameworks aligned with international standards, covering product classification and dedicated GMP standards specifically for ATMPs. This ensures that products developed by Thai innovators meet global standards and can confidently compete in international markets. 2. Serving as a Strategic Partner for Researchers and Entrepreneurs (Proactive Partnership) The FDA has implemented a Pre-submission Consultation mechanism to provide technical guidance before formal approval applications are submitted. It has also introduced Fast Track pathways for products addressing urgent medical needs, helping reduce unnecessary delays and barriers while maintaining patient safety as the highest priority. 3. Building an "Ecosystem of Trust" (Ecosystem of Trust) The FDA oversees clinical trials to ensure ethical compliance and maintains long-term post-market safety monitoring systems. This is intended to build confidence among both patients and healthcare professionals that these innovations will remain effective and safe in a sustainable manner. Mr. Surachai Ruengsuksilp, Honorary Chairman of the Pharmaceutical Industry Group under the Federation of Thai Industries and Vice President of the Thai Pharmaceutical Manufacturers Association (TPMA), stated that the pharmaceutical industry is not merely an economic driver, but also a "critical infrastructure for national security." Currently, Thailand's pharmaceutical market is valued at more than THB 240 billion. Amid these opportunities, the Federation of Thai Industries has established a strategic direction to position Thailand as a full-fledged Regional Pharma Hub through three key strategies: 1.Transforming from an "Importer" to a "Producer for Security" Reducing dependence on imported medicines by promoting domestic production of Active Pharmaceutical Ingredients (APIs), thereby reducing vulnerability to global crises. 2. Upgrading from "Basic Medicines" to "Advanced Innovation" Supporting Thai pharmaceutical manufacturers in upgrading to internationally recognized PIC/S GMP standards, enabling Thai medicines not only to serve the CLMV market but also to expand exports globally. 3. Building a Strong Pharmaceutical Ecosystem Driving collaboration with the government and the Board of Investment (BOI) to create an investment environment conducive to research and development, while also reforming procurement regulations to better reflect actual quality-based costs. This is intended to help Thai pharmaceutical companies remain competitive and achieve sustainable growth. The Federation of Thai Industries aims to make Thailand "a regional production base for high-quality and affordable medicines," focusing not only on economic growth figures, but also on ensuring that Thai people have sufficient access to safe medicines under all circumstances. Dr.Ponthip Wirachwong Ph.D. Deputy Managing Director, Government Pharmaceutical Organization (GPO), stated that beyond its primary role in pharmaceutical manufacturing, the organization's core mission is to ensure confidence in Thailand's healthcare system by guaranteeing that Thai people will never face medicine shortages during crises or at any time. In the past, Thailand has experienced epidemics and natural disasters, and the GPO has maintained reserve systems for essential medicines and medical supplies to ensure that hospital operations can continue without disruption caused by delays. "Even the most advanced medicine fails if it remains out of reach. GPO's mission is simple: ensure every Thai patient has access to safe, quality medicines — at a price that doesn't force them to choose between health and survival," she said. -- SOURCE : Informa Markets

BANGKOK, May 24, 2026 /PRNewswire/ — Informa Markets sets to organise CPHI South East Asia from 8–10 July 2026 at Queen Sirikit National Convention Center under the theme “The Gateway to the ASEAN Pharma Industry.” The event is a comprehensive pharmaceutical manufacturing exhibition, technology showcase, and conference for Southeast Asia, featuring innovations from more than […]

HSA 2026 To Serve As Platform To Boost Ecosystem, Public-Private Healthcare Collaboration

KUALA LUMPUR, May 20 -- The hosting of the Health Summit Asia (HSA) 2026 is expected to serve as a catalyst in strengthening the regional healthcare ecosystem through the gathering of industry players, medical technology experts and policymakers from within and outside the country to explore future healthcare solutions. Deputy Health Minister Datuk Hanifah Hajar Taib said the platform would also create opportunities for stronger collaboration between the government and private sector in enhancing the national healthcare system, particularly through the sharing of technology, innovation and the latest expertise. She said through exhibitions and discussion sessions involving local and international industry players, various new technologies and innovations in the healthcare sector could be highlighted not only in Malaysia but also across Asia. “If we think about it, it is not necessarily the Ministry of Health (MOH) or the Malaysian government that knows every type of technology or breakthrough available from other countries or local industries. “So through exhibitions and discussions like this, we can further strengthen understanding and facilitate solutions to more complex health problems,” she told reporters after launching HSA 2026 here today. Also present were Green Wellness Malaysia founder and managing director Datin Dorph Peng and Qube Integrated Malaysia executive chairman Richard Teo. The three-day conference, jointly organised by Qube Integrated Malaysia and Green Wellness Malaysia, is expected to attract more than 10,000 delegates, over 100 exhibitors and participation from more than 40 global and regional speakers, while targeting the generation of up to RM1.5 billion in commercial opportunities within the ASEAN healthcare and wellness economy. Meanwhile, commenting on the issue of drug-laced vapes or “zombie vapes”, Hanifah Hajar said MOH continuously monitors the current situation while conducting awareness programmes in schools to educate students on the dangers of vaping to health. “If there are vapes containing drugs and not produced by registered companies, we need to work together with the police, customs and enforcement authorities to ensure such matters cannot be compromised,” she said. On the Ebola situation, she said the Ebola vaccine has yet to be registered in Malaysia, but the ministry is making early preparations, including identifying procurement and logistics processes should the vaccine be required in the future. “We want to ensure that if needed, we are fully prepared to bring the vaccine into Malaysia,” she said. Earlier, MOH in a statement today said no Ebola cases have been reported in Malaysia so far, but preparedness measures are being further strengthened in view of the risk of imported cases through international travel following outbreaks in Congo and Uganda. -- BERNAMA

KUALA LUMPUR, May 20 — The hosting of the Health Summit Asia (HSA) 2026 is expected to serve as a catalyst in strengthening the regional healthcare ecosystem through the gathering of industry players, medical technology experts and policymakers from within and outside the country to explore future healthcare solutions. Deputy Health Minister Datuk Hanifah Hajar […]

Ujana Tenaga PETRONAS Chronicles Terengganu’s Energy Journey

KUALA TERENGGANU, May 19– The Petroleum Gallery at the Terengganu State Museum, which has been upgraded to Ujana Tenaga PETRONAS (PETRONAS Energy Garden), chronicles the story of energy, PETRONAS’ heritage, and technological advancement in a way that resonates with the public. PETRONAS senior vice president (Project Delivery and Technology) Ir. Mohd Yusri Mohamed Yusof said […]

S. Korea To Test AI-based Smart City Tech In Southeast Asia

SEOUL, April 13 (Bernama-Yonhap) -- South Korea will carry out pilot projects to test smart city technologies based on artificial intelligence (AI) in five Southeast Asian countries, including Malaysia, aimed at helping address urban challenges and support domestic firms' global expansions, the land ministry said Monday. According to Yonhap News Agency, the ministry said it has selected six projects to be carried out in five countries under its 2026 K-City Network programme, an initiative that supports the application of domestic smart city projects. In Brunei, an AI-based smart city platform will be tested to improve water management and disaster response, while a smart traffic management system will help optimise traffic signals in Bacoor of the Philippines. Projects in Vietnam will help introduce on-demand transport services in Ho Chi Minh City and deploy AI-based smart intersection control systems in Can Tho to improve traffic flow. Additional projects include implementing a safety management solution for ageing buildings in Surin, Thailand, and deploying a traffic management system in Penang, Malaysia, to detect accidents and congestion. The ministry said the programme is expected to help validate the effectiveness of Korean smart technologies in overseas markets and lead to follow-up exports and investment opportunities.

SEOUL, April 13 (Bernama-Yonhap) — South Korea will carry out pilot projects to test smart city technologies based on artificial intelligence (AI) in five Southeast Asian countries, including Malaysia, aimed at helping address urban challenges and support domestic firms’ global expansions, the land ministry said Monday. According to Yonhap News Agency, the ministry said it […]